Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Conotruncal Defects”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableUnknownNCT00005102
What this trial is testing

Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome

Who this might be right for
DiGeorge SyndromeShprintzen SyndromeChromosome Abnormalities+2 more
National Center for Research Resources (NCRR) 11
Not applicableStudy completedNCT00004361
What this trial is testing

Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects

Who this might be right for
HypoparathyroidismTetralogy of FallotPulmonary Valve Stenosis+3 more
National Center for Research Resources (NCRR) 150
Not applicableStudy completedNCT02541058
What this trial is testing

Non-Invasive Chromosomal Evaluation of 22q11.2

Who this might be right for
22q.11.2 Deletion/Duplication
Cindy Cisneros 420
Not applicableStudy completedNCT01460316
What this trial is testing

Conotruncal Cardiac Defects and Nutrigenetic Etiopathogeny

Who this might be right for
Conotruncal Cardiac Defects
Central Hospital, Nancy, France 400
Not applicableUnknownNCT02503267
What this trial is testing

"Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects"

Who this might be right for
Congenital Heart DiseasesConotruncal DefectsCongenital Disorder of Glycosylation+1 more
Hospital Universitari Vall d'Hebron Research Institute 300
Testing effectiveness (Phase 2)Study completedNCT05149898
What this trial is testing

Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE)

Who this might be right for
22Q11.2 Deletion Syndrome
Harmony Biosciences Management, Inc. 20